4
Changes in Ownership
MoonLake Immunotherapeutics Filed Acc 0001213900-22-024301
Options or other derivatives
- Director acquired 45,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Phillips Andrew John Director | 2022-04-06 | Grant or award · Option to Buy | +45,000 | 45,000 | D | ||
Loading xslF345X03/ownership.xml…